Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Samadzadeh

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Biomedicines|February 26, 2025
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of ProgressVito A G Ricigliano, Silvia Marenna, Serena Borrelli, et al.
Frontiers in Neurology|June 19, 2026
Global overview of multiple sclerosis care units: an international cross-sectional surveyPer Soelberg Sörensen, Paola F Zaratin, Mario Alberto Battaglia, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2025
Comorbidity and cardiovascular risk factors in multiple sclerosisMahdi Barzegar, Sara Samadzadeh, Kosar Kohandel, et al.
Annals of Clinical and Translational Neurology|December 1, 2020
Long-term adherence and response to botulinum toxin in different indicationsJohn-Ih Lee, Alexander Jansen, Sara Samadzadeh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2026
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseGerardina Gallaccio, Anna Müller, Meng Wang, et al.
Brain : a Journal of Neurology|September 8, 2025
The postdoc paradox: a career without a pathJonathan Pansieri, Sandy Figiel, David Menassa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspectsSara Samadzadeh, Mads Nikolaj Olesen, Martin Wirenfeldt, et al.
Brain : a Journal of Neurology|June 9, 2025
Academia in the throes of faceless bureaucracyJonathan Pansieri, David Menassa, Sandy Figiel, et al.
Frontiers in Immunology|July 18, 2024
Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)Sara Samadzadeh, Rafl Adnan, Paulina Berglova, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 29, 2026
Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivityRoya Abolfazli, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Biomedicines|February 26, 2025
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of ProgressVito A G Ricigliano, Silvia Marenna, Serena Borrelli, et al.
Frontiers in Neurology|June 19, 2026
Global overview of multiple sclerosis care units: an international cross-sectional surveyPer Soelberg Sörensen, Paola F Zaratin, Mario Alberto Battaglia, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2025
Comorbidity and cardiovascular risk factors in multiple sclerosisMahdi Barzegar, Sara Samadzadeh, Kosar Kohandel, et al.
Annals of Clinical and Translational Neurology|December 1, 2020
Long-term adherence and response to botulinum toxin in different indicationsJohn-Ih Lee, Alexander Jansen, Sara Samadzadeh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2026
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseGerardina Gallaccio, Anna Müller, Meng Wang, et al.
Brain : a Journal of Neurology|September 8, 2025
The postdoc paradox: a career without a pathJonathan Pansieri, Sandy Figiel, David Menassa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspectsSara Samadzadeh, Mads Nikolaj Olesen, Martin Wirenfeldt, et al.
Brain : a Journal of Neurology|June 9, 2025
Academia in the throes of faceless bureaucracyJonathan Pansieri, David Menassa, Sandy Figiel, et al.
Frontiers in Immunology|July 18, 2024
Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)Sara Samadzadeh, Rafl Adnan, Paulina Berglova, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 29, 2026
Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivityRoya Abolfazli, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.
Pageof 8